Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015)

Jazz Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $50.0 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 40.09% year-over-year to $50.0 million; the TTM figure through Sep 2015 stood at $50.0 million (up 40.09% YoY), while the FY2014 annual figure was $48.4 million, up 44.11% from the prior year.
• Current Deferred Tax Assets for Q3 2015 stood at $50.0 million, down from $50.6 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $50.8 million in Q1 2015, with the low at $33.6 million in Q4 2013.
• The 4-year median for Current Deferred Tax Assets is $46.1 million (2013), against an average of $43.0 million.
• Peak annual rise in Current Deferred Tax Assets reached 44.11% in 2014, while the deepest fall reached 24.47% in 2014.
• Jazz Pharmaceuticals' Current Deferred Tax Assets stood at $35.8 million in 2012, then slipped by 6.14% to $33.6 million in 2013, then surged by 44.11% to $48.4 million in 2014, then climbed by 3.23% to $50.0 million in 2015.
• Business Quant data shows JAZZ's Current Deferred Tax Assets at $50.0 million in Q3 2015, $50.6 million in Q2 2015, and $50.8 million in Q1 2015.